Latest News

• 26 Nov 2020 – Destiny Pharma – Result of General Meeting and Total Voting Rights
• 25 Nov 2020 – Destiny Pharma announces total gross proceeds raised via Open Offer
• 18 Nov 2020 – Antibiotic Resistance: A Matter of Time – FT
• 09 Nov 2020 – Destiny Pharma to acquire Phase 3 ready C.difficile program and announces fund raising
• 12 Oct 2020 – Clinical Study Patient Recruitment Update
• 01 Oct 2020 – Destiny Pharma welcomes proposed PASTEUR Act in USA
• 17 Sep 2020 – Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical infections
• 17 Sep 2020 – Interim results for the 6 months ended 30 June 2020
• 10 Sep 2020 – Scrip article “Destiny Pharma and SporeGen back Nasal Spray over Vaccine to tackle COVID-19”
• 07 Sep 2020 – Destiny Pharma and SporeGen® announce collaboration and Innovate UK grant award to co-develop novel, preventative treatment for COVID-19